Participating in Multidisciplinary Policy Development for Immuno-Oncology
In Partnership With
Ryan Weight, DO discusses takeaways from the Immuno-Oncology Institute Working Group Summit. The summit was a part of the Association of Community Cancer Centers’ Immuno-Oncology Institute and brought together multidisciplinary working groups to strategize policy and delivery changes for the effective use of immunotherapy.
Ryan Weight, DO, an assistant professor of medicine, University of Colorado Health Cancer Center, discusses takeaways from the 2018 Immuno-Oncology Institute Working Group Summit. The summit was a part of the Association of Community Cancer Centers’ Immuno-Oncology Institute and brought together multidisciplinary working groups to strategize policy and delivery changes for the effective use of immunotherapy. Weight shares knowledge around the 4 working groups of physicians, nurses, mid-level providers, and healthcare administrators who aim to understand and address the issues related to immuno-oncology (IO) care.
Within 2 of the working groups at the summit, the participants discussed the role of big data and telemedicine in IO. Another working group focused on care, education, and coordination. The fourth working group examined the role of multispecialty care in IO.
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
